New combo therapy aims to make inoperable stomach cancer removable
Disease control
Not yet recruiting
This study tests a combination of heated chemotherapy delivered directly to the abdomen (HIPEC), standard chemotherapy (NIPS), and an immunotherapy drug (tislelizumab) in 30 people with stomach cancer that has spread to the lining of the abdomen. The goal is to shrink the cancer …
Phase: PHASE2 • Sponsor: Hebei Medical University • Aim: Disease control
Last updated May 09, 2026 01:34 UTC